Su1384 EUS-GUIDED RADIOFREQUENCY ABLATION (EUS-RFA) FOR PANCREATIC NEUROENDOCRINE TUMORS AND CYSTIC MUCINOUS NEOPLASMS: A PILOT STUDY OF SAFETY, FEASIBILITY AND EFFICACY

Preliminary case-reports deem EUS-RFA as a potential effective therapy for selected patients with pancreatic malignancies unfit for or refusing surgery. Recent development of EUS-RFA catheters opens up a potential, minimally invasive treatment option. However, there are scarce data about their real safety, efficcacy and type of lesions potentially treatables. We aimed to assess the feasibility, efficacy, adverse events and early results of EUS-RFA for pancreatic neuroendocrine tumors (PNET) and cystic mucinous neoplasms (CMN)

https://ift.tt/2xsDJoJ